Double immunostaining for the characterization of IL-21R immunopositive (IL-21R+) cells in the intestine from non-IBD controls and patients with CD was performed with markers for T cells (CD3), B cells (CD20), plasma cells (CD138), or macrophages (CD68). This evidence concerns the gene IL21R and inflammatory bowel disease.